PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
56.81
ESG score 80-90% of RNAZ's 63.21. Walter Schloss would scrutinize governance quality and regulatory exposure.
51.50
Environmental score 90-95% of RNAZ's 55.41. Bill Ackman would demand clear environmental improvement catalysts.
59.27
Social score 80-90% of RNAZ's 67.22. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
59.67
Governance score 80-90% of RNAZ's 67.01. Walter Schloss would scrutinize management accountability and board independence.
